AI Commercialization Strategies for DeepTech Innovation

In the MediaMetrics interview "The Art of AI," Loran Jacobs outlined proven strategies for AI commercialization and academic tech transfer.

Joined by Neurobotics CEO Vladimir Konyshev, Loran spoke in his capacity as Executive Director of the MIPT R&D Center and Deputy CEO of Neurobotics. He shared practical insights on translating fundamental scientific research into commercial deeptech solutions.

Bridging Academia and Market: AI Commercialization in Practice

During the interview, Loran Jacobs addressed the core challenges scientists face when transitioning from academic research to commercial ventures. As a leading artificial intelligence authority, he emphasized that modern scientific careers require a fluid combination of mathematical theory and software engineering.

"Programming represents the triumph of applied mathematics, converting abstract formulas into real software solutions," explains Loran.

He also pointed out that formal employment registries fail to capture rapid developments in fields like neurorobotics and artificial intelligence.

"Rigid professional titles limit talent growth. Future experts must focus on solving multidisciplinary societal challenges rather than fitting into legacy job definitions," emphasizes Loran.

Furthermore, the AI scientist holding double Ph.D. in Quantum Physics & Abstract Algebra highlighted how neuroscience feeds directly into machine learning models, noting that brain research allows engineers to optimize artificial neural network architectures.

The Growth of Rehabilitation Robotics and Healthcare Tech

Loran Jacobs also examined changing market dynamics in hardware and medical robotics. While traditional industrial robotics shipped 400,000 units in 2018 reaching a $19.5 billion market without AI, collaborative systems represent a growing $1 billion sector where software accounts for 30% of total value.

In healthcare, traditional care faces significant specialist shortages. Russia experiences 450,000 to 600,000 annual stroke cases, while post-stroke economic losses across Europe reach €450 billion.

"Automated rehabilitation robotics helps treat patients within the critical six-month recovery window," notes Loran Jacobs.

Clinical trials in leading medical centers also confirmed that anthropomorphic speech-therapy robots reduce patient anxiety during cognitive exercises.

"Social robotics is proving its value in clinical settings by lowering patient anxiety during cognitive rehab," adds Loran.

Scaling DeepTech Solutions for Human Impact

Connecting fundamental research with enterprise transformation remains a top priority for deeptech ecosystems. As international markets adopt medical technologies, the DeepTech pioneer demonstrated that successful technology transfer depends on cross-disciplinary collaboration and outcome-focused frameworks.

By focusing product development on measurable human impact, National AI Award recipient Loran V. Jacobs, PhD continues to offer a strategic blueprint for sustainable growth across the global AI landscape.